Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar

Table 4 Annual commodities, programmatic expenses, time and travel cost

Scenario (societal)	Total cost	Drug and RDT costs (scaled to uptake)		Programmatic staff and non-commodity costs	Patient and provider time costs *	Provider travel costs **
Scenario (societal)	Total cost	Total	(RDT donor only)	Programmatic staff and non-commodity costs	Patient and provider time costs *	Provider travel costs **
No intervention	$96,996	$95,614	$0	$0	$1,382	$0
Arm 1: simple subsidy	$625,486	$103,658	$1,037	$387,735	$54,748	$79,344
Arm 2: subsidy with financial incentive	$626,342	$104,087	$1,382	$388,163	$54,748	$79,344
Arm 3: subsidy with IEC	$734,339	$119,127	$4,147	$476,973	$58,896	$79,344

*Includes time spent conducting RDT, and provider time for monthly supply point visit based on wages, as providers were not compensated by the programme.
**Patient travel costs were excluded and were the same across each arm, estimated to be $504,000 per arm.
Bold = donor costs.

ISSN: 1475-2875